Open AccessAssessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever
Author(s) -
Nielsen Søren Saxmose,
Alvarez Julio,
Bicout Dominique Joseph,
Calistri Paolo,
Canali Elisabetta,
Drewe Julian Ashley,
GarinBastuji Bruno,
Gonzales Rojas José Luis,
Gortázar Schmidt Christian,
Herskin Mette,
Michel Virginie,
Miranda Chueca Miguel Ángel,
Padalino Barbara,
Pasquali Paolo,
Sihvonen Liisa Helena,
Spoolder Hans,
Ståhl Karl,
Velarde Antonio,
Viltrop Arvo,
Winckler Christoph,
Gubbins Simon,
Stegeman Jan Arend,
Antoniou SotiriaEleni,
Aznar Inma,
Broglia Alessandro,
Lima Eliana,
Van der Stede Yves,
Zancanaro Gabriele,
Roberts Helen Clare
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6707
Subject(s) - animal health , animal welfare , health claims on food labels , library science , veterinary medicine , classics , medicine , history , biology , food science , computer science , ecology
EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation ( EU ) 2016/429 on transmissible animal diseases (‘Animal Health Law’). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for Classical swine fever ( CSF ). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radii of the protection and surveillance zones, and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, details of the model used for answering these questions are presented in this opinion as well as the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Here, several recommendations are given on how to increase the effectiveness of some of the sampling procedures. Based on the average length of the period between virus introduction and the reporting of a CSF suspicion, the monitoring period was assessed as non‐effective. In a similar way, it was recommended that the length of the measures in the protection and surveillance zones were increased from 15 to 25 days in the protection zone and from 30 to 40 days in the surveillance zone. Finally, the analysis of existing Kernels for CSF suggested that the radius of the protection and the surveillance zones comprise 99% of the infections from an affected establishment if transmission occurred. Recommendations provided for each of the scenarios assessed aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to CSF .